Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endometrial Cancer, Endometrial Neoplasm”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07041606
What this trial is testing

An Observational Study of Molecular profIling of Advanced and aggRessive ENdometrial Cancer and 1-st Line Treatment Approaches in Russian Federation

Who this might be right for
Endometrial Cancer
AstraZeneca 500
Early research (Phase 1)UnknownNCT02433626
What this trial is testing

Study of COTI-2 as Monotherapy or Combination Therapy for the Treatment of Malignancies

Who this might be right for
Ovarian CancerFallopian Tube CancerEndometrial Cancer+7 more
Critical Outcome Technologies Inc. 51
Large-scale testing (Phase 3)Ended earlyNCT04159155
What this trial is testing

Various Treatments in Serous or p53 Abnormal Endometrial Cancer

Who this might be right for
Endometrial CarcinomaP53 MutationSerous Carcinoma
University Health Network, Toronto 11
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06942377
What this trial is testing

Calcium Channel Blocker Amlodipine for Endometrial Cancer Therapy

Who this might be right for
Endometrial Cancer
Peking University People's Hospital 140
Not applicableLooking for participantsNCT05366881
What this trial is testing

CfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

Who this might be right for
Brain CancerBreast CancerBladder Cancer+17 more
Adela, Inc 7,000
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07453394
What this trial is testing

QLS5132 Combination Therapy in Advanced Solid Tumors

Who this might be right for
Gastric Cancer (GC)Non-small Cell Lung Cancer (NSCLC)Endometrial Cancer+2 more
Qilu Pharmaceutical Co., Ltd. 626
Testing effectiveness (Phase 2)Looking for participantsNCT06758557
What this trial is testing

Evaluate the Safety and Efficacy of HB0025 Injection in Patients With Advanced Solid Tumor

Who this might be right for
Advanced NSCLCAdvanced Endometrial Cancer
Huabo Biopharm Co., Ltd. 282
Not applicableStudy completedNCT01961102
What this trial is testing

OSCAR ENDO One Stop Assessment of Risk for Endometrial Hyperplasia and Cancer

Who this might be right for
Endometrial CancerAtypical Hyperplasia
Krankenhaus Barmherzige Schwestern Linz 300
Not applicableLooking for participantsNCT06800612
What this trial is testing

Evaluating Efficacy and Tolerability of Anticancer Drug Therapies for the Treatment of Gynecologic and Breast Cancers

Who this might be right for
Breast Cancer Early Stage Breast Cancer (Stage 1-3)Breast Cancer MetastaticOvarian Cancer+2 more
IRCCS Azienda Ospedaliero-Universitaria di Bologna 100
Not applicableNot Yet RecruitingNCT07189702
What this trial is testing

Plant-Based Nutrition for Breast or Endometrial Cancer

Who this might be right for
Breast Cancer MetastaticEndometrial Cancer Stage IV
University of Rochester 60
Testing effectiveness (Phase 2)Ended earlyNCT04030429
What this trial is testing

Crizotinib in c-MET Mutation Metastatic/Recurrent/Persistent Endometrial Cancer

Who this might be right for
Endometrial Cancer Recurrent
National Cheng-Kung University Hospital 40
Testing effectiveness (Phase 2)Ended earlyNCT00988845
What this trial is testing

Indole-3-Carbinol Effects on Estrogen Metabolism

Who this might be right for
Obesity
University of Wisconsin, Madison 38
Not applicableLooking for participantsNCT05427058
What this trial is testing

Hypogastric Plexus Block and Ganglion Impar Block for Cervical and Endometrial Cancer Pain Management

Who this might be right for
Cervical CancerEndometrial Cancer
University of Brawijaya 36
Early research (Phase 1)Not Yet RecruitingNCT07814248
What this trial is testing

A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors

Who this might be right for
NSCLC (Non-small Cell Lung Cancer)HNSCCEndometrial+5 more
TwoStep Therapeutics, Inc. 74
Testing effectiveness (Phase 2)Study completedNCT01631552
What this trial is testing

Study of Sacituzumab Govitecan-hziy (IMMU-132) in Adults With Epithelial Cancer

Who this might be right for
Gastric AdenocarcinomaEsophageal CancerHepatocellular Carcinoma+13 more
Gilead Sciences 515
Not applicableStudy completedNCT03207126
What this trial is testing

Pilot Study: Can Ultrasound Guided Biopsy be Used as an Alternative to Hysteroscopy?

Who this might be right for
Endometrial CancerEndometrial NeoplasmsEndometrial Hyperplasia+1 more
Imperial College London 10
Not applicableStudy completedNCT04212910
What this trial is testing

Stratifying Endometrial Cancer Patients Using a PET/MRI Prognostic Model

Who this might be right for
Endometrium Cancer
IRCCS San Raffaele 86
Not applicableStudy completedNCT03456791
What this trial is testing

Human Epididymis Protein 4 in Endometrial Carcinoma

Who this might be right for
Endometrial Cancer
Ain Shams University 84
Testing effectiveness (Phase 2)Not Yet RecruitingNCT05550558
What this trial is testing

Camrelizumab Plus Anlotinib in Patients With Recurrent Sporadic MMRd Endometrial Cancer

Who this might be right for
Endometrial Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 43
Not applicableStudy completedNCT00899496
What this trial is testing

Laboratory Assay in Determining Cancer Resistance in Patients With Metastatic Cancer and in Healthy Participants

Who this might be right for
Cancer
Wake Forest University Health Sciences 54
Next Page